The “Personalized diagnosis and treatment of hyperinsulinemic hypoglycaemia caused by beta-cell pathology” (BetaCure) project was funded by the European Commission with a 6 Million Euros FP7 grant in 2013. The EARL Taskforce EU grants facilitated this grant application, which is its first great success. EARL is the leader of work package „Training, dissemination, quality control“.

For further information on the project, please refer to the video of M. Gotthardt, coordinator of the BetaCure EU-Project, on youtube.

>> print article